Hartnup Disease
from OrphaChat — a Rare Disease Podcast Hosted by RCH
These sources collectively describe Hartnup disease, a rare autosomal recessive metabolic disorder caused by mutations in the SLC6A19 gene. This genetic defect impairs the transport of neutral amino acids, particularly tryptophan, within the kidneys and gastrointestinal tract, leading to their excessive excretion in urine. While many affected individuals remain asymptomatic, others may develop symptoms such as photosensitive skin rashes, ataxia, and various neurological or psychiatric issues. Research highlights how certain protein variants are trapped within the endoplasmic reticulum, further disrupting cellular functions and the localization of accessory proteins like ACE2. Management typically involves nutritional support, such as niacinamide supplementation, alongside physical and speech therapies to address specific symptomatic complications. Additionally, the broader medical context includes information on patient advocacy groups, diagnostic coding, and the role of lipid-based adjuvants in related immunological research.
Embed this episode
No transcript yet.